Meiji Yasuda Life Insurance CO Seagen Inc. Transaction History

Meiji Yasuda Life Insurance CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $201,552 - $268,363	-1,490 Reduced 26.15%	4,207 $576,000
Q1 2022 May 17, 2022	BUY	$119.61 - $157.85 $37,079 - $48,933	310 Added 5.75%	5,697 $821,000
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $441,594 - $526,442	3,100 Added 135.55%	5,387 $915,000
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $376,508 - $484,683	2,287 New	2,287 $401,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Meiji Yasuda Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Meiji Yasuda Life Insurance CO with notifications on news.